GLP-1R–positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Liraglutide, a glucagon-like peptide-1 (GLP-1) analog, is approved for obesity treatment, but the specific neuronal sites that contribute to its therapeutic effects remain elusive. Here, we show that GLP-1 receptor-positive (GLP-1R-positive) neurons in the lateral septum (LSGLP-1R) play a critical role in mediating the anorectic and weight-loss effects of liraglutide. LSGLP-1R neurons were robustly activated by liraglutide, and chemogenetic activation of these neurons dramatically suppressed feeding. Targeted knockdown of GLP-1 receptors within the LS, but not in the hypothalamus, substantially attenuated liraglutide's ability to inhibit feeding and lower body weight. The activity of LSGLP-1R neurons rapidly decreased during naturalistic feeding episodes, while synaptic inactivation of LSGLP-1R neurons diminished the anorexic effects triggered by liraglutide. Together, these findings offer critical insights into the functional role of LSGLP-1R neurons in the physiological regulation of energy homeostasis and delineate their instrumental role in mediating the pharmacological efficacy of liraglutide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The individual necessity of distinct GLP-1R neuron populations for the anorectic and weight loss effects of GLP-1RAs has now been claimed by multiple studies using various loss-of-function approaches in rodents (47, 50‐54, 69).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [54]
In the citing paper
“While the hypothalamic arcuate nucleus is the convergence region most investigated to date (20, 51, 52), several recent studies have provided evidence for roles in physiological and GLP-1RA AOM-mediated eating control for GLP-1R populations in the locus coeruleus (50), dorsomedial hypothalamus (53), and lateral septum (54) (Fig. 1B).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170 · cited 3×
“Liraglutide, acting similarly to native GLP-1 (4), modulates energy homeostasis by activating G protein–coupled receptors (2, 5–8).”
Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Platt, R. J., Chen, S., Zhou, Y., Yim, M. J., Swiech, L., Kempton, H. R., Dahlman, J. E., Parnas, O., Eisenhaure, T. M., Jovanovic, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.014 · Cited by 2,001 · cited 1×
“We injected an adeno-associated virus (AAV) containing GLP-1R –targeting single-guide RNA (sgRNA) and Cre-inducible mCherry into the dLS of GLP-1R-ires-Cre mice bred with Cre-inducible Cas9 knockin mice (34) (Figure 2A).”
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Buse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60659-0 · Cited by 1,503 · cited 2×
“Nausea is one of the most common adverse side effects reported with GLP-1R agonists, such as liraglutide (40–42).”
BackgroundAstrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163 · cited 2×
“Liraglutide, along with other GLP-1R agonists, not only diminishes food intake but also frequently elicits some side effects, such as nausea (41, 42, 56).”
BackgroundAnti-obesity drug discovery: advances and challenges
Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00337-8 · Cited by 1,021
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961 · cited 3×
“Evidence supporting this concept is provided by the binding of fluorescently labeled liraglutide to neurons in the Arc and specific hypothalamic regions in mice (49).”
Background
Cited by
Brain control of energy homeostasis: implications for anti-obesity pharmacotherapy
Johansen, V. B. I., Petersen, J., Lund, J., Mathiesen, C. V., Fenselau, H., & Clemmensen, C. (2025) · Cell · doi:10.1016/j.cell.2025.06.010 · Cited by 53
The neurobiology of overeating
Stuber, G. D., Schwitzgebel, V., & Lüscher, C. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.010 · Cited by 75
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Jones, L. A., & Brierley, D. I. (2025) · Endocrinology · doi:10.1210/endocr/bqae167 · Cited by 43
Park, J. S., Kim, K. S., & Choi, H. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0106 · Cited by 60
Semaglutide effects on energy balance are mediated by Adcyap1+ neurons in the dorsal vagal complex
Teixidor-Deulofeu, J., Sköldheden, S. B., Font‐Gironès, F., Feješ, A., Ruud, J., & Engström, L. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.018 · Cited by 38
Edvardsson, C. E., Cadeddu, D., Ericson, M., Adermark, L., & Jerlhag, E. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105684 · Cited by 33
GLP-1 physiology and pharmacology along the gut-brain axis
Beutler, L. R. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194744 · Cited by 35
Gaggini, M., Sabatino, L., Suman, A. F., Chatzianagnostou, K., & Vassalle, C. (2025) · Cells · doi:10.3390/cells14050387 · Cited by 35
Deng, S., Chen, Z., & Shi, Y. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01486-8 · Cited by 30
State-dependent central synaptic regulation by GLP-1 is essential for energy homeostasis
Wang, L., Savani, R. H., Lu, Y., Bernabucci, M., Luis-Islas, J., Park, E., Singh, I., Xu, W., Ouaamari, A. E., Wheeler, M. B., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01305-x · Cited by 23
Austin, G., Oqua, A. I., Eid, L. E., Zhu, M., Manchanda, Y., Peres, P., Coyle, H., Poliakova, Y., Balkhiyarova, Z., Bouzakri, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66115-x · Cited by 21
Yada, T., Dezaki, K., & Iwasaki, Y. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00168.2025 · Cited by 16
GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity
Kumar, V. (2025) · Open Biology · doi:10.1098/rsob.240303 · Cited by 19
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala
Duran, M., Willis, J. R., Dalvi, N., Fokakis, Z. N., VIRKUS, S., & Hardaway, J. A. (2025) · Endocrinology · doi:10.1210/endocr/bqaf019 · Cited by 13
Yacawych, W. T., Wang, Y., Zhou, G., Hassan, S., Bodur, Ç., Walters, E., Santinga, J. G., Sass, F., DeVaux, M., Kernodle, S., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci193743 · Cited by 19
Glucagon-Like Peptide 1 (GLP-1) Action on Hypothalamic Feeding Circuits
Hwang, E., Portillo, B., & Williams, K. W. (2025) · Endocrinology · doi:10.1210/endocr/bqaf125 · Cited by 10
Novel neural pathways targeted by GLP-1R agonists and bariatric surgery
Hankir, M. K., & Lutz, T. A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03047-3 · Cited by 16
Hunting for heroes: Brain neurons mediating GLP-1R agonists in obesity treatment
Cao, Y., & Tong, Q. (2024) · Obesity Medicine · doi:10.1016/j.obmed.2024.100569 · Cited by 10
He, X., Zhao, Z., Sun, Y., & Jiang, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118163 · Cited by 8
Shevchouk, O. T., Edvardsson, C. E., Ericson, M., Sköldheden, S. B., Zhang, Q., Nabinger, D. D., Snoeren, E. M. S., Westberg, L., & Jerlhag, E. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116085 · Cited by 9
Shen, J., Wang, M., Pang, G., Zhang, Y., Zhang, J., Shi, Y., Liu, J., & Zhan, C. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00528.2024 · Cited by 7
Uncovering the role of Gpr45 in obesity regulation
Karolczak, E. O., Li, C., Alcantara, I. C., Cohen, I. M., Gao, C., Xiao, C., Goldschmidt, A. I., Pinkus, C. A., Li, J., Li, M. M., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102174 · Cited by 9
The role of GLP-1 receptor in pain disorders and its pharmacological properties
Jing, F., Zeng, Y., Yu, Q.-L., & Fu, C. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178345 · Cited by 6
Yang, Y., Chen, L., Zhang, Y., Fu, W., Liu, D., & Jiang, T. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1607443 · Cited by 7
Cassano, D., Aguggia, J. P., Giovanini, L., Heredia, F., Francesco, P. N. D., Andreoli, M. F., Schöth, H. B., Habib, A. M., Fernández, G., & Perelló, M. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112627 · Cited by 3
Lateral Septum as a Key Integrative Regulator of Feeding: Role of the GLP ‐1/ GLP ‐ 1R System
Dib, T., Covarrubias, M. J., Escobar, A. P., Renard, G. M., Bravo, J. A., & Sotomayor‐Zárate, R. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70301 · Cited by 3
Jiménez‐Panizo, A., Johnson, T. A., Wagh, K., Alegre‐Martí, A., Montoya-Novoa, I., Lafuente, A. L., Eckhard, U., Rodríguez‐Lumbreras, L. A., Hoang, L., Stortz, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.13.653693 · Cited by 3
Wang, T., Cui, Y., & Liao, L. (2025) · Diabetes Therapy · doi:10.1007/s13300-024-01689-1 · Cited by 5
Hunger Games: A Modern Battle Between Stress and Appetite
Smith, W., & Azevedo, E. P. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70006 · Cited by 3
Individual paraventricular hypothalamic GLP-1R neurons track ingestion across energy states
Savani, R. H., Wang, L., Lu, Y., Le, T., Park, E., Yang, M., Pang, Z. P., & Rossi, M. A. (2025) · iScience · doi:10.1016/j.isci.2025.114070 · Cited by 2
Belančić, A., Şener, Y. Z., Vučković, M., Blais, J. E., Fajkić, A., Sher, E. K., Radić, M., & Radić, J. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70378 · Cited by 4
Tian, Y., Liu, Y., Jing, H., Shi, C., Li, Y., Dong, S., Li, L., Chen, B., Chen, Y., He, J., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.02.019 · Cited by 5
Schéle, E., Stoltenborg, I., Poelman, R., Adan, R. A. H., & Dickson, S. L. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.06.006 · Cited by 2
Sun, X., Yin, Y., Song, M., Droz, B. A., LIN, Y., Beaty, K. N., Zhou, B., Roh, H. C., Wilson, J. M., Cain, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.18.695152 · Cited by 2
Mechanisms of glucagon-like-peptide 1 in the brain beyond metabolic effects
Kim, K. S., Park, J. S., & Choi, H. J. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2448320.160 · Cited by 3
Insights into the mechanisms of body weight control
Pereira, S. (2025) · AJP Advances in Physiology Education · doi:10.1152/advan.00091.2025 · Cited by 1
Xie, J., Yang, Y., Chen, W., (45927), L. W., Weng, S., Lyu, Q., & Cao, G. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00722-7 · Cited by 1
The central amygdala gates exogenous glucagon-like peptide 1 signals
Duran, M., Zeng, N., Cutts, E. J., POLAMARASETTY, A., Rodríguez, M., Habegger, K. M., & Hardaway, J. A. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102403 · Cited by 2
GLP-1RA: New Hope in Obesity Therapy
Zhang, D., & Lu, H. (2025) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2025.132035
A guide to the brain areas that inhibit eating
(2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29218-7.15001-1
High-fat diet disrupts a septal control on feeding to promote obesity in male mice
Jiang, S., Lai, S., Jing, H., Wu, X., Li, F., Chen, B., Bao, J., Wang, L., Chen, G., & Zhu, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-68010-x
Heng, Y., & Qiuming, Y. (2026) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2026.103032
Targeting Multiple Gut‐Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy
Miras, A. D., & Hussain, M. (2026) · Obesity Science & Practice · doi:10.1002/osp4.70141 · Cited by 1
The central amygdala integrates exogenous glucagon-like peptide 1 signalsPreprint
Duran, M., Zeng, N., Cutts, E. J., Habegger, K. M., & Hardaway, J. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.06.716705
Covarrubias, M. J., Dib, T., Escobar-Luna, J., Moreno, R. D., Cáceres-Vergara, D., Saldías, C., Renard, G. M., Iturriaga‐Vásquez, P., Escobar, A. P., Torres, G. E., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1801283
Wei, K., Yu, M., Gao, L., Zhang, Q., Ding, J., zhang, Q., & Hu, G. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.05.031
Murugadoss, K., Venkatakrishnan, A., & Soundararajan, V. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-026-00131-3
Fu, H., Liu, Z., Zhou, J., Zhang, L., Liu, C., Tang, D., Zhang, S., Li, A., & Wang, D. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3004044
Jiménez‐Panizo, A., Johnson, T. A., Wagh, K., Alegre‐Martí, A., Montoya-Novoa, I., Lafuente, A. L., Eckhard, U., Rodríguez‐Lumbreras, L. A., Hoang, L., Stortz, M., et al. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.15659398
Metadata
- Authors
- Chen, Z., Deng, X., Shi, C., Jing, H., Tian, Y., Zhong, J., Chen, G., Xu, Y., Luo, Y., & Zhu, Y.
- Affiliations
- Chinese Academy of Sciences (CN)
- Hunan Normal University (CN)
- City University of Hong Kong (HK)
- Corresponding author
- Zhu, Yingjie
- Venue
- Journal of Clinical Investigation
- Published
- 2024-09-03
- Volume
- 134
- Issue
- 17
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC11364389
- OpenAlex
- W4402124375
- Cited by
- 48
- References
- 58
- Citations by year
- 2026: 13 · 2025: 32 · 2024: 3
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- CityU Scholars (submittedVersion, cc-by)
- Funders
- Major Project of the Science and Technology Innovation 2030 of China (2021ZD0202103)
- National Natural Science Foundation of China (82171492,32200827,82271534)
- Department of Science and Technology of Guangdong Province (2023B1515040009,2024A1515011612)
- Science, Technology and Innovation Commission of Shenzhen (RCJC20200714114556103,ZDSYS20190902093601675,JCYJ20210324141201003)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- liraglutide, GLP-1 receptor, lateral septum, anorectic effect, weight loss, obesity treatment, feeding behavior, energy homeostasis, chemogenetic activation, synaptic inhibition, GLP-1 analogues
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Liraglutide, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Appetite Depressants, Male, Neurons, Septal Nuclei, Weight Loss, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.